Pivotal Trial in Canine Elbow Arthritis Now 25% Enrolled

Today R-NAV enrolled our 12th subject in a pivotal trial for the treatment of canine elbow osteoarthritis.  The trial now is 25% enrolled.

Leave a Reply

Your email address will not be published. Required fields are marked *